MKI67 and breast cancer: Serum dyslipidemia, characterized by elevated total cholesterol and LDL-C levels and reduced HDL-C and apolipoprotein A1, was strongly correlated with Ki-67 expression levels and indicated a poor prognosis in breast cancer (including TNBC) patients [199].